Professor Usha Menon

Citirano

	Sve	Od 2020.
Citati	40610	19442
H-indeks	90	62
i10-indeks	340	257

4200

2100

1050

3150

20032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025124 163 234 310 383 385 494 685 862 1102 1399 1557 1857 2368 2597 2825 3064 3741 3761 4129 3411 3771 590

Javni pristup

Prikaži sve

329 članaka

8 članaka

dostupno

nije dostupno

Na temelju uvjeta financiranja

Suautori

Ian JacobsPresident & Vice Chancellor, University of New South Wales, Sydney, AustraliaPotvrđena adresa e-pošte na unsw.edu.au
Ranjit ManchandaProfessor of Gynaecological Oncology and Consultant Gynaecological OncologistPotvrđena adresa e-pošte na qmul.ac.uk
Steven SkatesMassachusetts General HospitalPotvrđena adresa e-pošte na mgh.harvard.edu
John F. TimmsUniversity College LondonPotvrđena adresa e-pošte na ucl.ac.uk
Susan RamusUniversity of New South WalesPotvrđena adresa e-pošte na unsw.edu.au
alexey zaikinProfessor, University College LondonPotvrđena adresa e-pošte na ucl.ac.uk
Anne LanceleyProfessor of Women's Cancer CarePotvrđena adresa e-pošte na ucl.ac.uk
a.mcguireProfessor of Health Economics, London School of EconomicsPotvrđena adresa e-pošte na lse.ac.uk
Saskia SandersonData Science Lead, UK Mental Health Mission, and Senior Research Fellow, King's College LondonPotvrđena adresa e-pošte na kcl.ac.uk
Robert BastMD Anderson Cancer CenterPotvrđena adresa e-pošte na mdanderson.org
Evans DG*, Evans G*University of ManchesterPotvrđena adresa e-pošte na mft.nhs.uk
Lesley J. FallowfieldDirector SHORE-C, University of SussexPotvrđena adresa e-pošte na sussex.ac.uk
Stephen PereiraUniversity College LondonPotvrđena adresa e-pošte na ucl.ac.uk
Paul PharoahCedars-Sinai Medical CenterPotvrđena adresa e-pošte na cshs.org
Andrew TeschendorffCAS Key Lab of Computational Biology, Shanghai Institute of Nutrition and Health, ShanghaiPotvrđena adresa e-pošte na sinh.ac.cn
Rainer CramerProfessor of Mass Spectrometry and Bioanalytical SciencesPotvrđena adresa e-pošte na reading.ac.uk
Ali TISSDasman Diabetes InstitutePotvrđena adresa e-pošte na dasmaninstitute.org
Alexander GammermanProfessor of Computer Science, Royal Holloway University of LondonPotvrđena adresa e-pošte na rhul.ac.uk
Nazar N Amso PhD, FRCOG, FHEAEmeritus Professor, Cardiff UniversityPotvrđena adresa e-pošte na cardiff.ac.uk
Peter SasieniProfessor of Cancer Prevention, King's College LondonPotvrđena adresa e-pošte na kcl.ac.uk

Prati

Professor Usha Menon

MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College

Potvrđena adresa e-pošte na ucl.ac.uk - Početna stranica

Cancer screening diagnosis risk prediction Biomarkers


Naslov Poredaj po navodima Poredaj po godini Poredaj po naslovu	Citirano Citirano	Godina
Rethinking ovarian cancer: recommendations for improving outcomes S Vaughan, JI Coward, RC Bast, A Berchuck, JS Berek, JD Brenton, ... Nature Reviews Cancer 11 (10), 719-725, 2011	1573	2011
Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017	1510	2017
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ... Nature reviews Cancer 15 (11), 668-679, 2015	1283	2015
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial IJ Jacobs, U Menon, A Ryan, A Gentry-Maharaj, M Burnell, JK Kalsi, ... The Lancet 387 (10022), 945-956, 2016	1251	2016
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies Collaborative Group on Hormonal Factors in Breast Cancer The lancet oncology 13 (11), 1141-1151, 2012	1241	2012
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies CL Pearce, C Templeman, MA Rossing, A Lee, AM Near, PM Webb, ... The lancet oncology 13 (4), 385-394, 2012	1148	2012
Polygenic risk scores for prediction of breast cancer and breast cancer subtypes N Mavaddat, K Michailidou, J Dennis, M Lush, L Fachal, A Lee, JP Tyrer, ... The American Journal of Human Genetics 104 (1), 21-34, 2019	1069	2019
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK … U Menon, A Gentry-Maharaj, R Hallett, A Ryan, M Burnell, A Sharma, ... The lancet oncology 10 (4), 327-340, 2009	1062	2009
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer AE Teschendorff, U Menon, A Gentry-Maharaj, SJ Ramus, ... Genome research 20 (4), 440-446, 2010	973	2010
Management of women who test positive for high-risk types of human papillomavirus: the HART study J Cuzick, A Szarewski, H Cubie, G Hulman, H Kitchener, D Luesley, ... The Lancet 362 (9399), 1871-1876, 2003	771	2003
Screening for ovarian cancer: a pilot randomised controlled trial IJ Jacobs, SJ Skates, N MacDonald, U Menon, AN Rosenthal, AP Davies, ... The Lancet 353 (9160), 1207-1210, 1999	735	1999
Progress and challenges in screening for early detection of ovarian cancer IJ Jacobs, U Menon Molecular & Cellular Proteomics 3 (4), 355-366, 2004	693	2004
New tumor markers: CA125 and beyond RC Bast, D Badgwell, Z Lu, R Marquez, D Rosen, J Liu, KA Baggerly, ... International Journal of Gynecologic Cancer 15 (Suppl 3), 2005	684	2005
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013	662	2013
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial U Menon, A Gentry-Maharaj, M Burnell, N Singh, A Ryan, C Karpinskyj, ... The Lancet 397 (10290), 2182-2193, 2021	581	2021
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer SJ Ramus, H Song, E Dicks, JP Tyrer, AN Rosenthal, MP Intermaggio, ... Journal of the National Cancer Institute 107 (11), djv214, 2015	531	2015
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study W Sieh, M Köbel, TA Longacre, DD Bowtell, A DeFazio, MT Goodman, ... The lancet oncology 14 (9), 853-862, 2013	492	2013
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017	465	2017
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ... Nature genetics 45 (4), 362-370, 2013	427	2013
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population H Song, E Dicks, SJ Ramus, JP Tyrer, MP Intermaggio, J Hayward, ... Journal of Clinical Oncology 33 (26), 2901-2907, 2015	415	2015

Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.

Članci 1–20

Godišnji broj citata

Dvostruki navodi

Spojeni navodi

Dodavanje suautoraSuautori

Prati

Citirano

Suautori